Rydex Series Fds, Biotechnology Fund H Class
Rydex Series Fds, Biotechnology Fund H Class (RYOAX)
The Rydex Series Fds Biotechnology Fund H Class (RYOAX) is a mutual fund that focuses on investing in companies within the biotechnology industry. This fund aims to provide investors with long-term capital appreciation by investing in a diverse portfolio of biotech companies. With a focus on the healthcare sector, this fund offers investors the potential for high growth and returns. The "H Class" designation indicates that this fund is available to institutional investors and has a higher minimum investment requirement. Overall, RYOAX offers investors the opportunity to participate in the rapidly evolving and innovative biotech industry.
RYOAX Mutual Fund Chart & Stats
- Previous Close
- $74.40
- Sub-Category
- Sector-Specific
- Total Liabilities
- $1.09M
- Expense Ratio
- 1.63%
- Holding Count
- 70
- Brand
- Rydex Series Funds
- Category
- Equity
- Total Assets
- 137.90M
- Shares Outstanding
- N/A
- 52-Week Range
- $55.69 - $77.59
RYOAX Mutual Fund News
RYOAX Mutual Fund Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| ABBVAbbvie | 8.17% |
| AMGNAmgen Inc | 5.05% |
| GILDGilead Sciences | 4.49% |
| VRTXVertex Pharmaceuticals Inc. | 4.32% |
| REGNRegeneron Pharmaceuticals | 2.93% |
| RVMDRevolution Medicines, Inc. | 2.48% |
| ALNYAlnylam Pharmaceuticals | 2.36% |
| ONCBeOne Medicines | 2.17% |
| MRNAModerna | 2.15% |
| BIIBBiogen Inc. | 2.13% |
| Total | 36.24% |
Recently Viewed
No data currently available






